Bulked-Up Glooko To Launch 'Unified' Diabetes Offering Next Year
Glooko and Diasend, two specialists in software solutions for diabetes management, have merged. With a new cash injection of $8m from venture investors, the combined company expects to launch its first product that brings together each entity's know-how next year.
You may also be interested in...
Glooko says it has found more success by pitching its diabetes management app to self-insured employers and to payers as a tool they can implement to reduce spending, rather than by pursuing reimbursement the traditional way. It's one model for the digital-health sector in the current health-care environment.
Minimally invasive glaucoma surgery specialist Glaukos saw its stock leap 40% in the wake of a worldwide recall by much bigger rival Alcon of its CyPass microstent.
Roland Diggelmann will end his decade-long career at Roche Diagnostics at the end of September. The business's head of EMEA Michael Heuer will take Diggelmann's place while the search is on for his replacement.